(PFX) Phenixfin - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US71742W1036

PhenixFIN Corporation is a business development company. The firm seeks to invest in privately negotiated debt and equity securities of small and middle market companies. It primarily invests in the following sectors: business services; buildings and real estate; automobile; oil and gas; aerospace and defense; home and office furnishings, housewares, and durable consumer products; healthcare, education and childcare; personal, food, and miscellaneous services; retail stores, diversified or conglomerate manufacturing; telecommunications; mining, steel, iron, and non-precious metals; leisure, amusement, motion pictures, and entertainment; chemicals, plastics, and rubber; finance; personal and nondurable consumer products (manufacturing only); beverage, food, and tobacco; containers, packaging, and glass; structure finance securities; machinery (non-agriculture, non-construction, non-electric); diversified or conglomerate service; restaurant and franchise; electronics; and cargo transport. The firm seeks to invest in companies located in North America. The firm targets private debt transactions in companies with enterprise values or asset values between $25 million and $250 million. The firm seeks to invest in companies with debt investment values between $10 million and $50 million. It exits its investments between three years and seven years; it holds most of its investments to maturity or repayment, but may realize or sell some investments earlier. The firm may take a board seat on its investee companies and can also offer managerial assistance to certain portfolio companies. It structures its investments as first lien senior secured loans, second lien senior secured loans, senior secured notes, senior subordinated notes, subordinate notes, unitranche loans, and seeks warrants or other equity participation. The firm may co-invest in privately negotiated transactions under certain conditions. PhenixFIN Corporation was founded in 2010 and is headquartered in New York, New York. Web URL: https://www.phenixfc.com/

Additional Sources for PFX Stock

PFX Stock Overview

Market Cap in USD 98m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Investment Banking & Brokerage
IPO / Inception 2011-01-21

PFX Stock Ratings

Growth 5y 42.9%
Fundamental 50.6%
Dividend 62.1%
Rel. Strength Industry -47.1
Analysts 3/5
Fair Price Momentum 47.43 USD
Fair Price DCF 184.95 USD

PFX Dividends

Dividend Yield 12m 5.06%
Yield on Cost 5y 6.14%
Annual Growth 5y 178.72%
Payout Consistency 54.0%

PFX Growth Ratios

Growth Correlation 3m 54.5%
Growth Correlation 12m 90.3%
Growth Correlation 5y 68.2%
CAGR 5y 4.13%
CAGR/Mean DD 5y 0.21
Sharpe Ratio 12m 1.21
Alpha 2.34
Beta 1.18
Volatility %
Current Volume 4.6k
Average Volume 20d 1.7k
What is the price of PFX stocks?
As of January 22, 2025, the stock is trading at USD 49.78 with a total of 4,585 shares traded.
Over the past week, the price has changed by +0.87%, over one month by -2.01%, over three months by +2.01% and over the past year by +18.50%.
Is Phenixfin a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Phenixfin (NASDAQ:PFX) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 50.57 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PFX as of January 2025 is 47.43. This means that PFX is currently overvalued and has a potential downside of -4.72%.
Is PFX a buy, sell or hold?
Phenixfin has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold PFX.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for PFX stock price target?
According to ValueRays Forecast Model, PFX Phenixfin will be worth about 53.1 in January 2026. The stock is currently trading at 49.78. This means that the stock has a potential upside of +6.59%.
Issuer Forecast Upside
Wallstreet Target Price 35 -29.7%
Analysts Target Price 35 -29.7%
ValueRay Target Price 53.1 6.6%